Collegium Pharmaceutical Inc (COLL)
33.55
+0.09
(+0.27%)
USD |
NASDAQ |
Nov 04, 13:06
Collegium Pharmaceutical Market Cap: 1.081B for Nov. 4, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 01, 2024 | 1.078B |
| October 31, 2024 | 1.100B |
| October 30, 2024 | 1.117B |
| October 29, 2024 | 1.135B |
| October 28, 2024 | 1.132B |
| October 25, 2024 | 1.118B |
| October 24, 2024 | 1.105B |
| October 23, 2024 | 1.156B |
| October 22, 2024 | 1.166B |
| October 21, 2024 | 1.175B |
| October 18, 2024 | 1.238B |
| October 17, 2024 | 1.254B |
| October 16, 2024 | 1.267B |
| October 15, 2024 | 1.241B |
| October 14, 2024 | 1.224B |
| October 11, 2024 | 1.215B |
| October 10, 2024 | 1.180B |
| October 09, 2024 | 1.210B |
| October 08, 2024 | 1.225B |
| October 07, 2024 | 1.282B |
| October 04, 2024 | 1.348B |
| October 03, 2024 | 1.285B |
| October 02, 2024 | 1.263B |
| October 01, 2024 | 1.279B |
| September 30, 2024 | 1.245B |
| Date | Value |
|---|---|
| September 27, 2024 | 1.232B |
| September 26, 2024 | 1.239B |
| September 25, 2024 | 1.205B |
| September 24, 2024 | 1.217B |
| September 23, 2024 | 1.231B |
| September 20, 2024 | 1.259B |
| September 19, 2024 | 1.254B |
| September 18, 2024 | 1.249B |
| September 17, 2024 | 1.204B |
| September 16, 2024 | 1.195B |
| September 13, 2024 | 1.208B |
| September 12, 2024 | 1.177B |
| September 11, 2024 | 1.166B |
| September 10, 2024 | 1.162B |
| September 09, 2024 | 1.182B |
| September 06, 2024 | 1.198B |
| September 05, 2024 | 1.212B |
| September 04, 2024 | 1.232B |
| September 03, 2024 | 1.205B |
| August 30, 2024 | 1.239B |
| August 29, 2024 | 1.244B |
| August 28, 2024 | 1.195B |
| August 27, 2024 | 1.217B |
| August 26, 2024 | 1.210B |
| August 23, 2024 | 1.168B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
449.26M
Minimum
Nov 04 2019
1.348B
Maximum
Oct 04 2024
789.79M
Average
749.32M
Median
Jun 28 2023
Market Cap Benchmarks
| Rigel Pharmaceuticals Inc | 248.79M |
| Esperion Therapeutics Inc | 394.41M |
| Context Therapeutics Inc | 168.75M |
| NovaBay Pharmaceuticals Inc | 3.652M |
| Palatin Technologies Inc | 23.07M |
Market Cap Related Metrics
| PE Ratio | 12.95 |
| PS Ratio | 2.699 |
| Price to Book Value | 4.990 |
| Price to Free Cash Flow | 5.648 |
| Price | 33.55 |
| Earnings Yield | 7.72% |
| Operating PE Ratio | 7.644 |
| Normalized PE Ratio | 12.38 |